Centralize content reviews
All reviewers work from a single source of truth, eliminating confusion around versions and approvals.
Read the article →
As content volume grows, pharma and biotech teams are turning to MLR software to streamline reviews, reduce compliance risk, and accelerate time to market. ERMA Evaluate™ identifies claims, assigns references, and flags FDA risk inside your assets.
MLR software is a technology platform designed to manage the review, approval, and compliance of pharmaceutical content. It enables medical, legal, regulatory, commercial, and agency teams to collaborate within a centralized workflow while maintaining complete audit trails and documentation.
Many organizations still rely on email chains, spreadsheets, and manual tracking. According to industry estimates, review cycles can take more than 40 days and involve multiple rounds of revisions before approval.
All reviewers work from a single source of truth, eliminating confusion around versions and approvals.
Every comment, decision, approval, and revision is automatically documented.
Automated routing, notifications, and role-based permissions reduce manual coordination.
AI identifies claims, validates references, and flags potential compliance concerns before human review.
Traditional platforms rely on static claims databases that require significant maintenance and quickly become outdated. AI-powered MLR software reduces review cycles while helping teams maintain regulatory confidence.
As FDA scrutiny increases and content volumes grow, evaluate solutions on the capabilities that drive both speed and compliance.
MLR software is a technology platform that manages the review, approval, and compliance of pharmaceutical content, letting medical, legal, regulatory, commercial, and agency teams collaborate in a centralized workflow with complete audit trails.
Medical, Legal, and Regulatory — the three functions that approve pharmaceutical promotional materials before use. The same process is also called PRC or medical review committee review.
With manual, email-driven processes, industry estimates put review cycles at more than 40 days with multiple rounds of revision. Modern AI-powered MLR software can significantly reduce that timeline.
AI automatically identifies claims, suggests supporting references, compares claims against approved sources, monitors evolving FDA guidance, and surfaces compliance risks earlier — without a static claims database to maintain.
Promotional materials, sales aids, website content, email campaigns, social media, medical affairs materials, scientific communications, and speaker program materials.
Real solutions for real MLR challenges